Newest Issue is Out. Get your exclusive copy today.

Subscribe for Free

Crucial Decision-making in Drug Development for COVID-19

A Decade of Reinforcing Business Integrity

WORKING TOGETHER, APART

DIGITAL SOLUTIONS IN DRUG DEVELOPMENT

PATIENT-CENTRIC CLINICAL TRIALS

Double-blinding Capsules for Clinical Trials

THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING

INTEGRATED CONTINUOUS BIOMANUFACTURING

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

THE DIGITALISATION OF THE CRYSTALLISATION PROCESS

ARTIFICIAL INTELLIGENCE IN PHARMACY PRACTICE

Get instant access to latest e-book

LATEST NEWSRead more...

04

Dec 2020

Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies

Tevard Biosciences a privatelyheld biotechnology company pioneering tRNAbased gene therapies and Zogenix a global biopharmaceutical company developing and commercializing rare disease therapies announced that the companies have entered into a collaboration to identify and develop novel tRNAbased gen...

04

Dec 2020

Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

Merck KGaA Darmstadt Germany a leading science and technology company and Artios Pharma Limited Artios a leading DNA Damage Response DDR company developing a broad pipeline of precision medicines for the treatment of cancer announced a global three year strategic research collaboration to discover a...

03

Dec 2020

Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA

Tubulis WuXi STA and WuXi Biologics announced a strategic collaboration to manufacture and advance Tubulis next generation antibodydrug conjugates ADCs towards INDenabling studies Tubulis has developed a dual platform approach to generate uniquely matched and diseasespecific ADCs that combine select...

03

Dec 2020

Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application

Exelixis Inc Iconic Therapeutics Inc Iconic and Zymeworks Incannounced that Exelixis has exercised its exclusive option for Iconics lead oncology antibodydrug conjugate ADC program under the companies May agreement

press releasesRead more...

04

Dec 2020

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy

ReAlta Life Sciences Incannounced that the European Medicines Agency EMA has granted Orphan Drug Designation to RLS also known as PICdPEG for the treatment of neonatal encephalopathy This designation builds on the Orphan Drug Designation that ReAlta received from the US Food and Drug Administration...

04

Dec 2020

I2O Therapeutics Receives Strategic Investment from Colorcon Ventures and Enters into Research Collaboration with Colorcon

IO Therapeutics an innovative biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs has received a strategic investment from Colorcon Ventures the corporate venture fund of Colorcon Inc In addition to this investment Colorcon will collaborate with...

03

Dec 2020

AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets

AbbVie a researchbased global biopharmaceutical company and Frontier Medicines Corp a precision medicine company drugging challenging protein targets to develop breakthrough medicines that change the course of human diseases announced a global strategic collaboration to discover develop and commerci...

03

Dec 2020

Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors

Catalyst Biosciences Incannounced the US Food and Drug Administration FDA has granted Fast Track Designation for Marzeptacog alfa activated or MarzAA the Companys subcutaneously SQ administered nextgeneration engineered coagulation Factor VIIa FVIIa for the treatment of episodic bleeding in subject...

EventsRead more...

01 - 04

Dec 2020

Pharma and Patient USA 2020

Reuters Events
Online

02 - 04

Dec 2020

Pharma Logistics 2020

Manch Exhibitions (Thailand) Co. Ltd
Bangkok International trade and Exhibition Centre (BITEC)

03 - 05

Dec 2020

Medical, Hospital & Pharmaceutical In Hanoi

Hanoi International Exhibition Center

04 - 05

Dec 2020

Pharmaceutical Research World Forum

Bucharest

Thermo Fisher Scientific - Chromatography Solutions

KNOWLEDGE BANK

Interviews

University of Lincoln, UK

Senior Lecturer, School of Pharmacy
Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy University of Lincoln Prior to Lincoln he had held many prestigious fellowships such as the Alexander von Humboldt fellowship Germany and Senior Research Fellowship DANIDA Denmark and CSIR India He is an organic chemist He has developed bioconjugations for DNA RNA and polymer modifications in water He is currently...

Articles

Advanced Nanobots for ‘Programmed’ Biomedical Applications

The idea of nanobots that could perform programmed tasks at targeted sites by traveling through biological fluids is no more in science fiction now Recent development in the field of nanotechnology provides the scope of designing miniaturised tiny nanobots which are even smaller than the dimension of biological cells

Research Insights

Near infra red spectroscopy as a multivariate process analytical tool for predicting pharmaceutical co-crystal concentration

Abstract The use of near infra red spectroscopy to predict the concentration of two pharmaceutical cocrystals ibuprofen nicotinamide IBUNIC and carbamazepine nicotinamide CBZNIC has been evaluated A Partial Least Squares PLS regression model was developed for both cocrystal pairs using sets of standard samples to create calib

Case Studies

Effects Of Particle Size On The Triboelectrification Phenomenon In Pharmaceutical Excipients: An Experimental Case Study

Abstract Particle sizes play a major role to mediate charge transfer both between identical and different material surfaces The study probes in to the probable mechanism that actuates opposite polarities between two different size fractions of the same material by analyzing the charge transfer patterns of two different sizes of MCC Quantum scale calculations

Techno Trends

The University of Bath Researchers Develop New Saliva Test to Detect Synthetic Drug

A simple saliva test has been developed by the researchers at the University of Bath to detect if someone has recently taken the street drug spice The substance known as spice is usually a mixture of dried and shredded plant material sprayed with various synthetic chemicals meant to mimic the main component of cannabis

White Papers

Key factors in the choice and development of a cleaning strategy - Fedegari Autoclavi SpA

Many aspects need to be considered in setting up a cleaning procedure This is certainly a multidisciplinary issue that involves various company areas from Regulations to Engineering from Quality Control lab to Production department Contributions of all these areas together can lead to a robust and reproducible cleaning process

Advisory Board

Stella

Sanjoy Ray

Rustom

Phil

Neil J

Laurence

Kenneth I

Georg C

Frank A

Douglas

Christopher-

Alan S Louie

EDITORIAL SECTION

STRATEGY

Natural Intelligence

Despite the hype the routine use of AI in marketing in the life sciences is a long way away

RESEARCH DEVELOPMENT

OCULAR DRUG DELIVERY PERSPECTIVE

As per the estimation of a Forbes analysis around US billion is spent by large pharmaceutical companiesfor a single drug approval

CLINICAL TRIALS

CLINICAL TRIALS IN A PETRI DISH

Clinical trials include experiments and the related observations done in clinical settings as part of prospective biomedical research studies on human...

MANUFACTURING

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

The constant requirement for the targeted delivery of therapeutically active agents has been the key driver in particle engineering and processing wit...

Information Technology

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

The cyberphysical security is no longer an area that should be overlooked Unfortunately cyberphysical attacks of all kinds may cost companies a great...

EXPERT Talk

PHARMA LOGISTICS TRENDS

Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...

Crucial Decision-making in Drug Development for COVID-19

A Decade of Reinforcing Business Integrity

WORKING TOGETHER, APART

DIGITAL SOLUTIONS IN DRUG DEVELOPMENT

PATIENT-CENTRIC CLINICAL TRIALS

Double-blinding Capsules for Clinical Trials

THE IMPORTANCE OF PRINCIPAL INVESTIGATOR TRAINING

INTEGRATED CONTINUOUS BIOMANUFACTURING

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

THE DIGITALISATION OF THE CRYSTALLISATION PROCESS

ARTIFICIAL INTELLIGENCE IN PHARMACY PRACTICE

Get instant access to latest e-book

LATEST NEWSRead more...

04

Tevard Biosciences and Zogenix Announce Collaboration to Advance Novel Gene Therapies

04

Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

03

Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA

03

Exelixis In-Licenses Iconic Therapeutics’ Tissue Factor-Targeting Antibody-Drug Conjugate Ahead of Planned Investigational New Drug Application

press releasesRead more...

04

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy

04

I2O Therapeutics Receives Strategic Investment from Colorcon Ventures and Enters into Research Collaboration with Colorcon

03

AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets

03

Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors

EventsRead more...

01 - 04

Pharma and Patient USA 2020

02 - 04

Pharma Logistics 2020

03 - 05

Medical, Hospital & Pharmaceutical In Hanoi

04 - 05

Pharmaceutical Research World Forum

TOP ARTICLES

1

Are We Ready to Ship Billions of COVID Vaccines Worldwide?

2

Personalised Therapy

3

Standard Operating Protocol (SOP) for The Clinical Diagnosis of Novel Coronavirus(COVID-19) Infection

4

Luminescent Carbon Dots: An Emerging Nanomedicine to Treat Antibiotic Resistant Bacterial Infections

5

Electronic Counters for Bottle Filling

KNOWLEDGE BANK

University of Lincoln, UK

Advanced Nanobots for ‘Programmed’ Biomedical Applications

Near infra red spectroscopy as a multivariate process analytical tool for predicting pharmaceutical co-crystal concentration

Effects Of Particle Size On The Triboelectrification Phenomenon In Pharmaceutical Excipients: An Experimental Case Study

The University of Bath Researchers Develop New Saliva Test to Detect Synthetic Drug

Key factors in the choice and development of a cleaning strategy - Fedegari Autoclavi SpA

Advisory Board

EDITORIAL SECTION

Natural Intelligence

OCULAR DRUG DELIVERY PERSPECTIVE

CLINICAL TRIALS IN A PETRI DISH

EMERGING TECHNOLOGIES FOR PARTICLE ENGINEERING

The Cyber-Physical Security of Pharmaceutical Manufacturing Processes

PHARMA LOGISTICS TRENDS